GORITRAZOLE

Filed: January 30, 2025
Therapeutic pharmaceutical for the treatment of Basal Cell Carcinomas in Gorlin Syndrome
Owned by: INHIBITOR Therapeutics, Inc.
Serial Number: 99023144